ETTX - Entasis Therapeutics Holdings Inc. (ETTX) CEO Manoussos Perros on Q2 2021 Results - Earnings Call Transcript

Entasis Therapeutics Holdings Inc. (ETTX) Q2 2021 Earnings Conference Call August 12, 2021 8:00 a.m. ET Company Participants Bruce Mackle - Managing Director, LifeSci Advisors Manoussos Perros - President and CEO Mike Gutch - CFO and Chief Business Officer David Altarac - Chief Medical Officer Conference Call Participants Matthew Luchini - BMO Capital Markets Ed Arce - H.C. Wainwright & Co. Presentation Operator Good morning, ladies and gentlemen, and welcome to the Entasis Therapeutics' Second Quarter Results Conference Call. Currently, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session, and instructions will follow at that time. As a reminder, this conference call is being recorded. I will now turn the call over to Bruce Mackle, Managing Director with LifeSci Advisors. Please go ahead, sir. Bruce Mackle Thank you, Alex. Before we proceed with the call, I would like to remind everyone that certain statements made

For further details see:

Entasis Therapeutics Holdings Inc. (ETTX) CEO Manoussos Perros on Q2 2021 Results - Earnings Call Transcript